Springboard Health Angels

At CGC Genomics (CGC) we are deeply committed to advancing the field of cancer care through complex, precision genomics analysis and report interpretation. We distill complex genomic data into concise, actionable insights for healthcare providers, reducing interpretation times and facilitating timely, personalized treatment recommendations for 10 million patients with metastatic cancer.​ Our years of experience interpreting and supporting thousands of the most complicated cancer genomics cases around the world enables CGC to offer healthcare providers timely, expert cancer genomics analysis and consultation support, delivering world-class expertise wherever and whenever needed.

Vivalyx Omnisol is a healthcare company dedicated to enhancing organ transplantation processes. It offers a comprehensive solution for organ preservation that utilizes patented technology to improve organ vitality and increase the number of available organs for transplantation. The company's approach eliminates the need for blood or human products, making it a cost-effective and efficient option for addressing organ failure. By focusing on the needs of patients suffering from organ failure worldwide, Vivalyx aims to support medical professionals in their efforts to improve transplant outcomes.

YonedaLabs is a developer of AI-based software designed to assist chemists in optimizing various reaction parameters, including temperature, concentration, and catalysts. Their platform aims to enhance the efficiency of chemical laboratories by streamlining the process involved in drug and material production. By leveraging artificial intelligence, YonedaLabs enables businesses to accelerate their research and development efforts, ultimately improving outcomes in the field of chemistry.

deepeye is a precision medicine platform focused on retinal diseases, specifically designed to enhance therapy outcomes for conditions such as Age-related Macular Degeneration (AMD). With a significant portion of the population in the EU and US affected by these diseases, deepeye aims to prevent blindness by enabling ophthalmologists to deliver tailored treatment plans. The platform utilizes artificial intelligence to analyze therapy data and develop deep learning models, providing valuable insights for pharmaceutical companies, payors, and healthcare providers. This technology supports ophthalmologists in offering individualized care, ensuring that patients receive the most effective interventions for their specific needs.

PharmaCCX, Inc. is a company that operates a market access platform designed to streamline the pricing and procurement of medicines for healthcare payers, thereby facilitating quicker patient access to necessary treatments. The platform primarily supports oncology pharmaceutical companies and various healthcare systems in the United States and Europe. Founded in 2017 and headquartered in Boston, Massachusetts, PharmaCCX also maintains offices in Stockholm, Sweden; San Mateo, California; and Zug, Switzerland. The company's software enhances the efficiency of market access teams within pharmaceutical companies and payers, enabling them to effectively plan, negotiate, and manage innovative payment models.

Tech-enabled healthcare solution for the underserved LGBTQIA+ community.

LEVY Health develops clinical decision support software specifically targeting endocrine disorders. The platform employs proprietary algorithms and clinical guidelines to streamline the diagnostic process, significantly reducing the time to diagnosis from an average of 4.5 years to just a few weeks. By focusing on infertility diagnostics and personalized therapeutic strategies, LEVY Health enhances users' chances of achieving pregnancy, offering a more efficient and effective approach to managing endocrine-related health issues.

Virtonomy GmbH specializes in clinical trial services utilizing virtual models of humans and various animals, including sheep, pigs, and calves. Founded in 2019 and based in Munich, Germany, the company provides services such as anatomy studies, virtual fittings, pre-operative planning, and visualization through advanced image analysis and three-dimensional anatomical models. Its platform helps medical device manufacturers optimize designs, ensuring better patient outcomes by reducing risks associated with vessel misalignment and sizing inaccuracies. By offering insights into device-anatomy interactions, Virtonomy enables the development of patient-specific implants and enhances the overall evaluation of clinical interventions in a virtual setting. The company's innovative approach aims to streamline the medical device development process, ultimately accelerating the delivery of safe and effective products to the market.

Operator of a cell-based biotechnology platform designed to produce messenger ribonucleic acid(mRNA) therapeutics and vaccines. The company's platform uses cell engineering, computational biology, and precision fermentation to optimize the production of vaccinia capping enzymes, enabling medical professionals to provide optimal medicines to their patients.

Acorai is developing a non-invasive heart failure monitoring platform centered on direct intracardiac pressure monitoring (ICPM). The company utilizes a patented combination of sensor technologies and machine learning to provide accurate and cost-efficient heart failure care. This innovative approach allows for non-invasive monitoring of cardiac and pulmonary pressure, which is crucial for improving outcomes in heart failure patients. By analyzing pressure dynamics through acoustic, vibratory, and waveform data, the device enables healthcare professionals to proactively adjust medications, potentially reducing re-hospitalization and mortality rates associated with heart failure. Clinically validated and designated as an FDA Breakthrough Device, Acorai's product is expected to enter the market in 2025.

Syndi is a digital health platform that focuses on enhancing health outcomes through technology and research, initially targeting mental health. The platform employs machine learning and digital phenotyping to provide personalized and immediate care by utilizing moment-by-moment passive smartphone data collection. This approach allows for effective and accessible support tailored to individual needs. Syndi's services aim to improve the treatment of invisible disabilities by facilitating connections between patients and healthcare providers, while also measuring the effectiveness of its applications and digital services. Through its innovative solutions, Syndi seeks to transform the way people access and engage with healthcare.

Recovery Cat is a developer of a therapy collaboration platform aimed at patients with severe mental disorders. The platform facilitates collective therapy planning and evaluation, offering valuable insights to both healthcare providers and patients. By monitoring patient responses to treatments for conditions such as schizophrenia, bipolar disorder, and recurrent depression, Recovery Cat empowers psychiatrists to adopt a patient-centric approach. This enables personalized follow-ups and helps identify patients at risk, thereby supporting engagement in treatment and timely responses to potential relapses.

Mirantus Health is a digital health company focused on enhancing access to care for underserved patients through a distributed healthcare model. The company offers Mirantus Care, which provides healthcare services, and Mirantus OS, a cloud-based solution that enables specialist physicians to efficiently diagnose and treat patients remotely. By integrating point-of-care diagnostics with telemedicine, Mirantus empowers doctors to reach patients who have previously been difficult to access. This approach not only improves healthcare access for over 100 million underserved individuals in Europe but also allows physicians to increase their earnings while significantly reducing costs for payors.

Akina is a company based in Zurich, Switzerland, founded in 2021, that specializes in developing artificial intelligence healthcare software aimed at enhancing physiotherapy. The software integrates evidence-based therapy with virtual coaching and entertainment, providing patients with tools to engage in independent physiotherapy at home. Akina's platform connects users to healthcare providers for remote monitoring and personalized guidance, utilizing proprietary AI motion analysis and media streaming algorithms. Additionally, it facilitates automated case reviews and feedback for therapists, ultimately improving the delivery of care and clinical outcomes for patients.

Phinomics is a precision-medicine platform company that specializes in identifying unique circular-DNA targets for therapeutic development and precision care. By leveraging cutting-edge genomic technologies, Phinomics focuses on extrachromosomal circular DNA to create innovative solutions that address unmet healthcare needs. The company's approach integrates artificial intelligence, single-cell analysis, and bioinformatics to discover novel molecular markers, enhancing targeted treatment therapies, clinical diagnostics, and drug discovery. This rigorous methodology allows for the clinical validation of previously hidden targets, ultimately empowering clinicians to prevent, diagnose, and treat disorders associated with changes in DNA.

Rekoo is an online clinic for stroke healing. They provide optimal care for every stroke patient by returning them to the center. They offer care systems, but they don't find the support they need, resulting in deficient recovery outcomes and skyrocketing care costs.